Donanemab may offer new hope for people with early Alzheimer’s disease

FHS
July 17, 2023
5:44 pm

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important advancement in Alzheimer’s research and treatment.

Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206 – Biotech Investments

EQS-News: Formycon AG / Key word(s): Study Formycon announces start of clinical phase III trial for Keytruda® biosimilar candidate FYB206 30.07.2024 / 06:50 CET/CEST The

July 31, 2024

Staph Infections Appear to Be More Deadly for Women

Female patients with Staphylococcus aureus bacteremia (SAB) had higher mortality risk than male patients, according to a systematic review and meta-analysis. In adjusted mortality data

February 28, 2024

Medicine Is Not Just at a Crossroads, It’s in a Crisis, AMA President Says

NATIONAL HARBOR, Md. — American Medical Association (AMA) President Jesse Ehrenfeld, MD, MPH, urged his fellow members to continue the good fight against the multifront

November 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.